Quick answer: In Mumbai, as of June 2026, a first month of doctor-supervised Mounjaro typically totals ₹17,000–₹19,500: ₹13,125 for the 2.5 mg KwikPen (MRP), ₹1,500–₹2,200 for an endocrinologist consult — Mumbai's are India's most expensive — and ₹2,000–₹3,500 for baseline blood tests. Generic semaglutide cuts the medicine line to as little as ₹1,290/month. All GLP-1s are prescription-only; online video consultations with registered doctors are fully legal and dramatically cheaper here.

Mumbai is India's biggest GLP-1 market — and its most expensive front door

When Mounjaro became India's top-selling drug by value in October 2025 (₹100 crore in a single month, per Pharmarack), industry reporting noted that Mumbai and Delhi accounted for the largest share of those sales. No surprise: Mumbai concentrates exactly the buyer this category serves — urban, salaried, time-poor, already paying for gyms and nutritionists that haven't worked.

What Mumbai also concentrates is the country's priciest specialist access. The medicine costs the same in Matunga as in Mysore — MRPs are national. The system around the medicine is where Mumbai charges a premium.

The first-month math, Mumbai edition

Line item Mumbai reality (June 2026)
Endocrinologist consult₹1,500–₹2,200 typical; up to ₹3,000 at specialty weight clinics
Baseline blood panel (HbA1c, lipids, TSH, LFT/KFT)₹2,000–₹3,500 at private labs
Mounjaro 2.5 mg KwikPen (month 1)₹13,125 MRP
Branded first month, in-person route≈ ₹17,000–₹19,500
Same month with generic semaglutide (e.g., Semanat vial)medicine line drops to ~₹1,290
Each 4-weekly titration follow-up thereafteranother ₹1,500–₹2,200 + half a day

Every line above moves with your dose and titration speed — run this math at your dose with the cost calculator, or see the full India GLP-1 cost guide for the national picture.

Where those consult numbers come from — current Practo listings across the city (June 2026):

Where Area Consult fee
Gleneagles HospitalParel₹2,200
S.L. Raheja (Fortis associate)Mahim₹2,000
Fortis HiranandaniVashi₹2,200
Apollo HospitalsBelapur, Navi Mumbai₹2,000
Specialty endocrine/weight clinicsChembur, Andheri, Mulund₹2,000–3,000
Dr. L H Hiranandani HospitalPowai₹1,100
Trust/charitable hospital OPDsByculla and othersfrom ₹300

The spread is real — a Powai resident can pay half what a Chembur one does — but the working range for an experienced obesity-focused endocrinologist in Mumbai is ₹1,500–₹2,200 per visit, recurring every four weeks through titration.

Then add the commute. GLP-1 titration is a monthly-touchpoint protocol for at least the first six months. If you live in Kandivali and your endocrinologist sits in Mahim or Parel, every follow-up is a local-train-plus-queue half day, twelve times a year. Mumbai's own math is the strongest argument in India for moving routine GLP-1 supervision online and saving in-person visits for when something genuinely needs hands on you.

Start in Mumbai without the local-train follow-ups

Video consult with a registered physician, labs collected at home anywhere in MMR, e-prescription valid at any licensed pharmacy — titration follow-ups included.

Where Mumbai buys GLP-1s

  1. Wellness Forever. The city's dominant 24/7 chain (Bandra to Borivali to Navi Mumbai); reliable for cold-chain branded pens against prescription, and increasingly stocking the new generics.
  2. Apollo Pharmacy & Noble Plus. Wide coverage across the island city, suburbs, and Thane; hospital-adjacent branches are best for same-day higher-dose stock.
  3. Hospital pharmacies. Lilavati (Bandra), Hinduja (Mahim), Kokilaben (Andheri), Jaslok (Pedder Road), Gleneagles (Parel), Apollo (Belapur) dispense GLP-1s including against outside prescriptions.
  4. Online cold-chain delivery. Tata 1mg, PharmEasy (a Mumbai company), and Apollo 24/7 deliver pens with ice packs across MMR, prescription upload mandatory. In monsoon months, take delivery personally — a pen sitting with a building watchman through an August afternoon is a cold-chain failure.
  5. The grey market. Mumbai's import-agent channels (Dubai stock, "no Rx needed") predate the 2025 launches and still exist. They are now pointless: legal, DCGI-approved generic semaglutide costs less than grey-market freight, and counterfeit KwikPens have been reported in Indian channels. If a deal skips the prescription, it's either illegal, fake, or both — verify batch numbers and seals and follow a safe-sourcing checklist.

One Mumbai-specific note on the generics: after the 20 March 2026 patent expiry, 40+ generic semaglutide brands launched (Natco's Semanat from ~₹1,290/month, Alkem's Semasize pens from ~₹1,800, Sun's Noveltreat, Dr. Reddy's Obeda, Zydus's Semaglyn). Novo Nordisk answered on 1 April 2026 with cuts of up to 48%, bringing Wegovy's starter dose to ₹5,660/month. Mounjaro (tirzepatide, a different molecule) remains patent-protected at ₹13,125–₹25,781/month. Mumbai chemists are stocking generics fastest in the western suburbs and Navi Mumbai; in South Mumbai, call ahead. Our semaglutide guide compares the options, and if you're already on Mounjaro and weighing the change, see how a supervised switch to generic semaglutide works.

Why online supervision works in this city

Mumbai's constraint isn't doctor quality — the city has some of India's best endocrinologists. It's throughput: their fees price out monthly contact, their OPDs price out your time, and the distances price out spontaneity. A structured online program inverts that — the doctor's attention comes to your schedule, follow-ups stop costing train journeys, labs come home, and the prescription gets filled at whichever Wellness Forever is on your walk home. Under the Telemedicine Practice Guidelines (2020), all of this is squarely legal: registered medical practitioners may evaluate by video and issue prescriptions valid at any licensed Indian pharmacy.

How Kaivo works if you're in Mumbai

Kaivo is built in Mumbai, for exactly this problem. A video consultation with a registered physician, baseline bloods collected at your home anywhere in MMR, an e-prescription you fill at any licensed pharmacy of your choice — Kaivo sells no medication and takes no markup, so the brand-versus-generic call is made on your clinical needs and budget, not a platform's margin. Then the part Mumbai's in-person economics can't deliver: 4-weekly titration reviews, between-visit support when week-2 nausea hits at 11 pm, plateau troubleshooting, and a maintenance plan from day one. The benchmarks supervision aims for: ~15% average loss at 68 weeks on semaglutide 2.4 mg (STEP-1), up to ~20.9% at 72 weeks on tirzepatide (SURMOUNT-1) — and crucially, keeping it after the taper.

Reading from another city? See our guides for Bangalore, Hyderabad, Delhi-NCR and Pune.

Sources

  1. Eli Lilly India — Mounjaro (tirzepatide) KwikPen MRPs by dose (₹13,125 / ₹16,406 / ₹20,625 / ₹25,781 per month), corroborated by May 2026 price trackers; no price cut announced as of June 2026.
  2. Reuters — Novo Nordisk India price reductions of up to 48% (Wegovy) and 36% (Ozempic) effective 1 April 2026; Wegovy 0.25 mg at ₹5,660/month.
  3. CNBC-TV18 / Business Today — post-patent generic semaglutide launches from 20 March 2026: 40+ DCGI-approved brands; Natco Semanat ~₹1,290/month, Alkem Semasize from ~₹1,800; Dr. Reddy's Obeda oral tablets (₹99/₹135/₹225), 20 May 2026.
  4. Pharmarack (via Reuters / CNBC-TV18) — Mounjaro India's top-selling drug by value from October 2025 (~₹100 crore/month); GLP-1 category MAT February 2026 ≈ ₹1,446 crore, +178% YoY; trade reporting placing Mumbai and Delhi as the largest sales concentrations.
  5. Practo — Mumbai endocrinologist and clinic consultation fee listings, pulled June 2026; re-verified quarterly.
  6. Telemedicine Practice Guidelines, Board of Governors (MCI) / Ministry of Health & Family Welfare, 25 March 2020.
  7. Wilding JPH et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP-1). NEJM 2021.
  8. Jastreboff AM et al. Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1). NEJM 2022.
This article is for education and does not replace medical advice, diagnosis or treatment. GLP-1 medicines are prescription drugs (Schedule H) in India; eligibility is determined only by a registered medical practitioner. The first-month total of ₹17,000–₹19,500 is a typical estimate composed from the cited components — your consult fee, lab panel and titration set the real number. Mounjaro® is a registered trademark of Eli Lilly and Company; Wegovy® and Ozempic® of Novo Nordisk; generic brand names belong to their respective makers. Hospital, clinic and pharmacy names appear solely as neutral statements of availability and pricing — Kaivo is not affiliated with, and does not imply endorsement by, any of them. Medically reviewed by Dr. Rinku Sarmah, MBBS, MD (Internal Medicine), AIIMS-trained — Clinical Lead, Kaivo. Last updated 10 June 2026.